Latin America & Caribbean vs Malawi: Antiretroviral therapy coverage
Latin America & Caribbean
71.6%
in 2024
Malawi
90.0%
in 2024
Latin America & Caribbean rank
19th
Malawi rank
18th
Antiretroviral therapy coverage over time
- Latin America & Caribbean
- Malawi
How they compare
Malawi currently reports 90.0% against 71.6% in Latin America & Caribbean, a difference of 18.4%.
That makes Malawi's figure about 1.3 times Latin America & Caribbean's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Latin America & Caribbean ahead.
Latin America & Caribbean ranks 19th and Malawi ranks 18th of 23 groups.
Across the 3 decades both report, Latin America & Caribbean averaged higher in 1 and Malawi in 2.
Head to head by decade
| Decade | Latin America & Caribbean | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.9% | 6.0% | 14.9% | Latin America & Caribbean |
| 2010s | 48.7% | 56.6% | 7.9% | Malawi |
| 2020s | 68.2% | 88.0% | 19.8% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Latin America & Caribbean or Malawi?
- Malawi, at 90.0% against 71.6% in Latin America & Caribbean as of 2024.
- What is the difference in antiretroviral therapy coverage between Latin America & Caribbean and Malawi?
- 18.4%, with Malawi ahead.
- How many years of comparable data are there for Latin America & Caribbean and Malawi?
- 25 years are reported by both, from 2000 to 2024.
- How do Latin America & Caribbean and Malawi rank globally for antiretroviral therapy coverage?
- Latin America & Caribbean ranks 19th and Malawi ranks 18th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.